Suzhou Sanegene Bio Inc

Suzhou Sanegene Bio Inc. develops innovative RNA (ribonucleic acid) interference (RNAi) therapeutics. The Company develops proprietary chemical modification platform and hepatic and extrahepatic delivery platform for RNA therapeutics of cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases. Suzhou Sanegene Bio conducts businesses in China and USA.